Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - EPS
EPS HALO - Halozyme Therapeutics, Inc.
2.13
LAST VALUE
-13.70%
2 YEAR CAGR
42.15%
5 YEAR CAGR
17.17%
10 YEAR CAGR